ArticleFrontiers in aging neuroscience2025
Machine learning study on predicting depressive symptoms and genetic correlations in Parkinson's disease.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metabolic dysfunction and insulin resistance across major dementias: A comprehensive narrative review of the TyG index as a predictive marker.Metabolism open · 2026Review
- Predicting Long-Term Depression Progression in Parkinson's Disease: A Machine-Learning Survival Analysis and Risk Score.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depressive symptoms are prevalent in individuals with Parkinson's disease. Previous research has demonstrated a significant association between the triglyceride glucose (TyG) index and depression. Leveraging multicenter clinical data, the present study evaluates the predictive capacity of the TyG index for depressive symptoms in PD patients, aiming to establish its potential role in identifying individuals at risk for depression. A comparative analysis of multiple machine learning models was conducted to predict depression in PD patients, ultimately selecting the most effective model. Key predictive variables, including diabetes status, sex, cholesterol levels, triglycerides, blood glucose, and sleep disturbances, were incorporated into a support vector machine (SVM)-based nomogram to assess depression risk in PD patients. Additionally, a genome-wide association study (GWAS) utilizing external databases confirmed a causal relationship between the TyG index and depression. Furthermore, this study explores the biological functions and molecular mechanisms underlying shared transcriptomic proteins between PD and depression, providing insights into potential pathophysiological links between the two conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.